WMT

99.26

+0.83%↑

COST

991.89

+0.53%↑

KR

71.44

+2.29%↑

TGT

101.71

-2.39%↓

GIS

51.8

-2.52%↓

WMT

99.26

+0.83%↑

COST

991.89

+0.53%↑

KR

71.44

+2.29%↑

TGT

101.71

-2.39%↓

GIS

51.8

-2.52%↓

WMT

99.26

+0.83%↑

COST

991.89

+0.53%↑

KR

71.44

+2.29%↑

TGT

101.71

-2.39%↓

GIS

51.8

-2.52%↓

WMT

99.26

+0.83%↑

COST

991.89

+0.53%↑

KR

71.44

+2.29%↑

TGT

101.71

-2.39%↓

GIS

51.8

-2.52%↓

WMT

99.26

+0.83%↑

COST

991.89

+0.53%↑

KR

71.44

+2.29%↑

TGT

101.71

-2.39%↓

GIS

51.8

-2.52%↓

Search

USANA Health Sciences Inc

Slēgts

32.12 -1.32

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

32.07

Max

32.89

Galvenie mērījumi

By Trading Economics

Ienākumi

4.8M

9.3M

Pārdošana

36M

250M

P/E

Sektora vidējais

16.775

27.516

EPS

0.73

Peļņas marža

3.723

Darbinieki

1,700

EBITDA

11M

27M

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 22. jūl.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

49M

569M

Iepriekšējā atvēršanas cena

33.44

Iepriekšējā slēgšanas cena

32.12

Tehniskais rādītājs

By Trading Central

Pārliecība

Weak Bullish Evidence

USANA Health Sciences Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 7. jūl. 15:29 UTC

Galvenie tirgus virzītāji

Mustang Bio Shares Jump After Orphan Drug Designation for Cancer Treatment

2025. g. 7. jūl. 23:44 UTC

Tirgus saruna

Nikkei May Fall on U.S. Tariff Concerns -- Market Talk

2025. g. 7. jūl. 23:44 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 7. jūl. 23:41 UTC

Tirgus saruna

Gold Edges Lower Amid Hopes for Possible Trade Agreements -- Market Talk

2025. g. 7. jūl. 23:19 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 7. jūl. 23:19 UTC

Tirgus saruna

AML3D Bull Sees Navy Letter Lowering Risks -- Market Talk

2025. g. 7. jūl. 22:20 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 7. jūl. 22:20 UTC

Tirgus saruna

AT&T's Fiber Strategy Positions Stock to Outperform -- Market Talk

2025. g. 7. jūl. 21:34 UTC

Iegādes, apvienošanās, pārņemšana

BlackRock's Latest Acquisition Is a Commercial Real Estate Bet -- Barrons.com

2025. g. 7. jūl. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 7. jūl. 20:45 UTC

Iegādes, apvienošanās, pārņemšana

CoreWeave Is Buying Core Scientific. The CEO Explains Why. -- Barrons.com

2025. g. 7. jūl. 20:16 UTC

Tirgus saruna

Canada Bonds Set to Benefit From Rotation Away U.S. Assets -- Market Talk

2025. g. 7. jūl. 19:37 UTC

Tirgus saruna

U.S. Natural Gas Futures Hold Their Ground -- Market Talk

2025. g. 7. jūl. 19:12 UTC

Tirgus saruna

Oil Futures Shrug Off Bigger OPEC+ Output Increase -- Market Talk

2025. g. 7. jūl. 18:33 UTC

Tirgus saruna

Gold Flat as Investors Assess Market Direction -- Market Talk

2025. g. 7. jūl. 18:27 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 7. jūl. 16:53 UTC

Peļņas

Freight Stocks Have a Tariff Overhang. Morgan Stanley Says It Could Be Worse. -- Barrons.com

2025. g. 7. jūl. 16:30 UTC

Tirgus saruna

Higher Prices Limit Power Sector's Natural Gas Use -- Market Talk

2025. g. 7. jūl. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 7. jūl. 16:05 UTC

Iegādes, apvienošanās, pārņemšana

CoreWeave Is Buying Core Scientific. The CEO Explains Why. -- Barrons.com

2025. g. 7. jūl. 15:41 UTC

Tirgus saruna

Gold Futures Fall as Stronger U.S. Dollar Undermines Safe-Haven Demand -- Market Talk

2025. g. 7. jūl. 15:41 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 7. jūl. 15:40 UTC

Tirgus saruna

Base Metal Prices Tick Lower on U.S. Dollar Strength -- Market Talk

2025. g. 7. jūl. 15:30 UTC

Tirgus saruna

Physical Oil Market Stable But Structural Weakness Looms -- Market Talk

2025. g. 7. jūl. 15:18 UTC

Tirgus saruna

BNP Cuts Brent Forecast on U.S. Shale, Iran Supply Resilience -- Market Talk

2025. g. 7. jūl. 15:14 UTC

Iegādes, apvienošanās, pārņemšana

MicroStrategy Goes a Week Without Buying Bitcoin. Saylor Has Advice for Crypto Traders. -- Barrons.com

2025. g. 7. jūl. 15:00 UTC

Iegādes, apvienošanās, pārņemšana

GSK Completes Acquisition of Efimosfermin

2025. g. 7. jūl. 14:52 UTC

Tirgus saruna

Dollar Faces Downward Pressures Stemming from Tariffs -- Market Talk

2025. g. 7. jūl. 14:51 UTC

Tirgus saruna

Bullish Factors Lift Oil Despite Downward Pressure -- Market Talk

2025. g. 7. jūl. 14:45 UTC

Tirgus saruna

Saudi Arabia Not Seeking to Take Oil Market Share -- Market Talk

Salīdzinājums

Cenas izmaiņa

USANA Health Sciences Inc Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

0

Pirkt

0

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

28.405 / 29.84Atbalsts un pretestība

Īstermiņā

Weak Bullish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

No Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.